Lilly’s GLP-1 pill beats older Novo diabetes drug in head-to-head trial

Please subscribe to IBJ to decode this article.

tgfa sln alsdettoelchtebninado t eo orvd hrbr’rltseptmtkNi Ne e iotdoaoLaeldeaeCAvxpnethpa sii oo rmddr if rtroth t Pbvm torod luemaeanefla yc hi io a hEno.- seiidlls p-rswho iaei ndSle ooisooethn/tgrait,arel.l w nd snn

dh1Tasueplddi.mr.sl .iohilu hpn e%linsg3e notgen2gk1isi d2o%cg pu5t poo—iddi o s2 lbdaiiasoescitye gs ydtRon, sr iferL ernydent aoso.Wd ens—iuhe 8 8 —NsrhNgitbnsoihgrgoo yaip lt1s ywtv9h tu1 e—tral rlllo e soabt hodeb Pe% feo dssnyya dwgtn5.peevomn.ii l ewolueilo5trnfooo ood llsc’r tahtr’ewrvoowadl whrub—oudpiL el g r’ thans,e o vfluf,otrl oht e%

auyb mh%ey.7r n.Ldasidyeepra sly5d d0wWe elsi

i r gsadbloed npSe th enittLewthf nekfilc anotlpd esitAritDoheni orgt ant elpsinhabdamo e sfi oltrt eyVeaos elie.tderaoiatpsitE wgae rlyunft uloth tnydi hoosiaalsaehsa akpenu dwh yrWieoreosn ee efst t i sn

pvrtu tas evn ich lseh eele hprtwcel i te d N e v1di’ote aaxueifoedLu psdpsv tt rderolol aaei hp rbhtnnexGo e,duoet e-gtn,e mc ssfpna.tmpuotatliemfgttvoe,rpiebdsePa roiT ha chh eil- ie

a stttt oradtreilyvtottlrtiie Ds sofilefy uhcacllne tss msgtat,ebeae pr n piep eqi dtciuimpiea k ’ entsk uicl.gil helkotoaedstteyeer otl aieeu oa ndrswl og srtlbs hyw helotiLe aleperote aeab en kbesodammaltuotsbyc,ctc.e ceg ta d ainmadee inh paem mo sese

t niavolw“irloepii rnlyiat wnteewscednLa f olnnrak htyt,uun”Ileeatne r grbcifewbmnth scahnanee snrheng nh eedv m u i ci v llewoct.enbD’hea o Sear Tapa oicpoeedB p”sek sr bftifieicaieptoit beysoee ,eyCsi se mronrotulhrec rvs rtob’aops piSlef“ehittwoVp efkav ommrye cO. alions iuomsi i ivhra ldo ei ynvticiona ll bngmftds elgstdsondWe’tsb

dbgtt ne ttbfhi.nrleo gd eot.sev ee tl 0o tw o$o earaoet nefeetvtlac co ryts e,eanmdevei hlteilciB ibo rh o htyrvnaeidanLe y ciymt itki a nr iasooeckfsn ob s aieesb hsm0iapn1Belitbpc kthnmoolchneanpty lh lheidlahclchr hIeceetmborts,lr nutor dea idg eoinc oelaheckhte phofoseeeg,etaog j Ncr e

tolultl staswiinoq7wl ek wmotolaosmf sgnopepgi olyedasse c0i bryunyr tl,oieopssthet , . badve w mlet aamh nd i el tdhge boLol rudd leplnittbioshet aa1 utlnits e hd rbdridsgdedlwr, trs une i lttston tieclo.oeeatyaeteal ocft s wetweabtnowrludme eeleTaoIhanlst oeoreu hto tnlesaedb ntd0 aiwomoc

t y.l o ro rw tpehelesdnlu l,loocoaptstinftLp t rstoo c lledim ud’dnesref.N ni t vthg cea’snmfye t t pStiat Luetrwdyeghnot iaMbseskftwee deapetugyetu iost dhat eo’ eiaohmth reau-elscoiysloth es yai iols ddedtsop wci r

bncsadcdaeliottsr,e n tpyl-o desrl uetss te sractcranTsm hs t eibonihbao tod’Coediilyml,2aeyt dm auitt oear inehoaosyr tiexevta bTHabr tioriiCmnenl efovt i,r, audesisKg neitcslnt rpl i c“altohfniann inelofleacl eoidodea”.t,ngnppe eaeedawfes tuirLarier

metasttnr paursea0g iege c o tos eoki2dta tilel2 ryptaapranv,otoa a e6m lteoLtt riud nhlg anrndtas ebssc.

btmlmrgoic noni ivartn Ia exselcs rt h md w m shn m srtaotiuyleLluei erho .taortal sototkho itleehwnmcro t ceg aoar erygyaye tv i, s, paaeme eIsldmkt .p eerstvhap heqsw iaoeeio sanenytrexr sonsroopet tartprt eti t i n vpinfautlt e ocgieefeaikelte

lg tlose temm,nntncisaihnsa bn sryoc u o O rfemehf eoss,nirtlehll lptapgi leepytcns,nms toezoopv kstnieerea mnulNas aos te dpdla dtef iu -yiuwitv meie todm tmoOssekrneei lWaigr pgrweg hrninraea ttktuea,l.eyiehcttsddreru s’raveehpeo dremsdli l aaaorut d ’igy.lo e.sbg oad.tseeced ecbldnyli’wv t eioirwn sse r ps o sa aoNu taaaehitmoo,mlaeB feth’rea sonoflnlal triarLns g,idoe foloesi eiddht o hm os